Publication

Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth

Downloadable Content

Persistent URL
Last modified
  • 03/03/2025
Type of Material
Authors
    Cristina T. Navarrete, University of MiamiLisa A. Wrage, RTI InternationalWaldemar A. Carlo, University of Alabama BirminghamMichele C. Walsh, Case Western Reserve UniversityWade Rich, University of California San DiegoMarie G. Gantz, RTI InternationalAbhik Das, RTI InternationalKurt Schibler, University of CincinnatiNancy S. Newman, University of California San DiegoAnthony Piazza, Emory UniversityBrenda B. Poindexter, Indiana University School of MedicineSeetha Shankaran, Wayne State UniversityPablo J. Sanchez, University of Texas Southwestern Medical CenterBrenda H. Morris, University of Texas Medical School at HoustonIvan D. Frantz III, Floating Hospital for Children at Tufts Medical CenterKrisa P. Van Meurs, Stanford UniversityC. Michael Cotten, Duke UniversityRichard A. Ehrenkranz, Yale UniversityEdward F. Bell, University of IowaKristi L. Watterberg, University of New MexicoRosemary D. Higgins, Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentShahnaz Duara, University of Miami
Language
  • English
Date
  • 2016-06-22
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2016 Elsevier Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0022-3476
Volume
  • 176
Start Page
  • 62
End Page
  • +
Grant/Funding Information
  • The National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute provided grant support for the Neonatal Research Network’s SUPPORT Trial.
  • Additional funding information is available at www.jpeds.com (Appendix).
Supplemental Material (URL)
Abstract
  • Objective: To test whether infants randomized to a lower oxygen saturation (peripheral capillary oxygen saturation [SpO 2 ]) target range while on supplemental oxygen from birth will have better growth velocity from birth to 36 weeks postmenstrual age (PMA) and less growth failure at 36 weeks PMA and 18-22 months corrected age. Study design: We evaluated a subgroup of 810 preterm infants from the Surfactant, Positive Pressure, and Oxygenation Randomized Trial, randomized at birth to lower (85%-89%, n = 402, PMA 26 ± 1 weeks, birth weight 839 ± 186 g) or higher (91%-95%, n = 408, PMA 26 ± 1 weeks, birth weight 840 ± 191 g) SpO 2 target ranges. Anthropometric measures were obtained at birth, postnatal days 7, 14, 21, and 28; then at 32 and 36 weeks PMA; and 18-22 months corrected age. Growth velocities were estimated with the exponential method and analyzed with linear mixed models. Poor growth outcome, defined as weight < 10th percentile at 36 weeks PMA and 18-22 months corrected age, was compared across the 2 treatment groups by the use of robust Poisson regression. Results: Growth outcomes including growth at 36 weeks PMA and 18-22 months corrected age, as well as growth velocity were similar in the lower and higher SpO 2 target groups. Conclusion: Targeting different oxygen saturation ranges between 85% and 95% from birth did not impact growth velocity or reduce growth failure in preterm infants.
Author Notes
  • Corresponding Author: Cristina T. Navarrete, P.O. Box 016960 (R-131), Miami, FL 33136; Tel 305-585-6408; Fax 305-545-6581; cnavarrete@med.miami.edu
Keywords
Research Categories
  • Environmental Sciences
  • Health Sciences, General

Tools

Relations

In Collection:

Items